EUVIMEDEUVIMED entdecken
Open Access

Hydroxychloroquine, QTc prolongation and risk of torsades de pointes

Sarah Subhan, Andy Wang, Subo Dey, Wei Tang, Wilbert S Aronow

Archives of Medical Science – Atherosclerotic Diseases · 17.08.2023 · 8 (1) · 75-80

DOI: 10.5114/amsad/169982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Medical Science – Atherosclerotic Diseases, online erschienen am 17.08.2023. Verfasst von Sarah Subhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydroxychloroquine (HCQ) is a common medication used for the treatment of rheumatic diseases. As a result of its widespread use during COVID-19, there are increasing concerns about its cardiotoxicity. HCQ is known to cause QTc prolongation, and its long-term use has been associated with cardiomyopathy and conduction abnormalities. Despite reports of ventricular arrhythmia in COVID-19 patients taking HCQ, there have been reassuring data in approved indications. HCQ has been in use for several decades with a good safety profile. In addition to better disease control and prevention of flares, it is associated with decreased risk of cardiovascular diseases. But given its small risk of cardiotoxicity, clinicians should be aware of this effect and monitor patients for developing cardiac symptoms.

Schlagwörter

Stichwörter der Autor:innen

COVID-19QTc prolongationcardiotoxicityhydroxychloroquinetorsades de pointes

Autor:innen und Institutionen

  • Departments of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USA.
  • Departments of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY, USA.

Zitieren

APA

Subhan, S., Wang, A., Dey, S., Tang, W., & Aronow, W. S. (2023). Hydroxychloroquine, QTc prolongation and risk of torsades de pointes. Archives of Medical Science – Atherosclerotic Diseases, 8(1), 75-80. https://doi.org/10.5114/amsad/169982

Vancouver

Subhan S, Wang A, Dey S, Tang W, Aronow WS. Hydroxychloroquine, QTc prolongation and risk of torsades de pointes. Archives of Medical Science – Atherosclerotic Diseases. 2023;8(1):75-80. doi:10.5114/amsad/169982

BibTeX
@article{Subhan2023,
  author = {Subhan, Sarah and Wang, Andy and Dey, Subo and Tang, Wei and Aronow, Wilbert S},
  title = {Hydroxychloroquine, QTc prolongation and risk of torsades de pointes},
  journal = {Archives of Medical Science – Atherosclerotic Diseases},
  year = {2023},
  volume = {8},
  number = {1},
  pages = {75--80},
  doi = {10.5114/amsad/169982}
}
Kostenlos starten →